| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | establishment or maintenance of microtubule cytoskeleton polarity | 3.37e-06 | 5 | 145 | 3 | GO:0030951 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cytoskeleton polarity | 2.77e-05 | 9 | 145 | 3 | GO:0030952 | |
| GeneOntologyCellularComponent | asymmetric synapse | PDE4B OGT ANK2 ANK3 LRFN3 MPDZ SLITRK3 SYNPO SLC30A1 DST CELSR3 ARFGAP1 IQSEC1 GRIN3A ATP2B2 | 1.43e-06 | 477 | 147 | 15 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic density | PDE4B ANK2 ANK3 LRFN3 MPDZ SLITRK3 SYNPO SLC30A1 DST CELSR3 ARFGAP1 IQSEC1 GRIN3A ATP2B2 | 3.79e-06 | 451 | 147 | 14 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | PDE4B OGT ANK2 ANK3 LRFN3 MPDZ SLITRK3 SYNPO SLC30A1 DST CELSR3 ARFGAP1 IQSEC1 GRIN3A ATP2B2 | 4.40e-06 | 523 | 147 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | microtubule end | 6.69e-06 | 38 | 147 | 5 | GO:1990752 | |
| GeneOntologyCellularComponent | postsynaptic specialization | PDE4B ANK2 ANK3 LRFN3 MPDZ SLITRK3 SYNPO SLC30A1 DST CELSR3 ARFGAP1 IQSEC1 GRIN3A ATP2B2 | 1.31e-05 | 503 | 147 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | microtubule plus-end | 4.21e-05 | 28 | 147 | 4 | GO:0035371 | |
| GeneOntologyCellularComponent | Z disc | 9.77e-05 | 151 | 147 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 1.76e-04 | 166 | 147 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | basal plasma membrane | 2.09e-04 | 354 | 147 | 10 | GO:0009925 | |
| GeneOntologyCellularComponent | supramolecular fiber | PDE4B EPPK1 ANK2 ANK3 SARM1 NUMA1 CAMSAP3 OBSL1 EVPL SYNPO LCP1 REEP2 DST SPHKAP KIF3C REEP4 DNAH9 PLS1 DYNC1H1 KIF2C | 2.28e-04 | 1179 | 147 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | PDE4B EPPK1 ANK2 ANK3 SARM1 NUMA1 CAMSAP3 OBSL1 EVPL SYNPO LCP1 REEP2 DST SPHKAP KIF3C REEP4 DNAH9 PLS1 DYNC1H1 KIF2C | 2.49e-04 | 1187 | 147 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | basal part of cell | 3.51e-04 | 378 | 147 | 10 | GO:0045178 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 4.48e-04 | 320 | 147 | 9 | GO:0016323 | |
| GeneOntologyCellularComponent | perinucleolar compartment | 4.84e-04 | 5 | 147 | 2 | GO:0097356 | |
| GeneOntologyCellularComponent | 3M complex | 4.84e-04 | 5 | 147 | 2 | GO:1990393 | |
| GeneOntologyCellularComponent | heterochromatin | 7.40e-04 | 101 | 147 | 5 | GO:0000792 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 8.63e-04 | 157 | 147 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | apical junction complex | 8.92e-04 | 158 | 147 | 6 | GO:0043296 | |
| GeneOntologyCellularComponent | microtubule minus-end | 1.01e-03 | 7 | 147 | 2 | GO:0036449 | |
| GeneOntologyCellularComponent | intercalated disc | 1.35e-03 | 68 | 147 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | sarcomere | 1.94e-03 | 249 | 147 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | postsynapse | PDE4B OGT ANK2 ANK3 LRFN3 MPDZ SLITRK3 SYNPO SLC30A1 DST CELSR3 ARFGAP1 IQSEC1 GRIN3A ATP2B2 KIF2C | 2.19e-03 | 1018 | 147 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | bicellular tight junction | 2.35e-03 | 131 | 147 | 5 | GO:0005923 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 2.51e-03 | 133 | 147 | 5 | GO:0005881 | |
| GeneOntologyCellularComponent | hemidesmosome | 2.59e-03 | 11 | 147 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | podosome | 2.99e-03 | 41 | 147 | 3 | GO:0002102 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.02e-03 | 201 | 147 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | tight junction | 3.04e-03 | 139 | 147 | 5 | GO:0070160 | |
| GeneOntologyCellularComponent | cell-cell junction | 3.12e-03 | 591 | 147 | 11 | GO:0005911 | |
| GeneOntologyCellularComponent | myofibril | 3.24e-03 | 273 | 147 | 7 | GO:0030016 | |
| MousePheno | abnormal placenta morphology | SMG1 MYCBP2 UBR4 CAMSAP3 LAMA5 POU2F1 SALL4 PTBP1 CHM NUBPL TRIP12 LEPR FOXD3 CELF1 TLN1 EIF3H | 1.44e-05 | 525 | 123 | 16 | MP:0001711 |
| Domain | ANK | POTEB3 ANK2 ANK3 POTED ANKRD27 POTEC ASAP2 ANKRA2 ANKDD1B ANKRD17 TNKS2 ANKFN1 | 6.69e-07 | 251 | 146 | 12 | SM00248 |
| Domain | ANK_REPEAT | POTEB3 ANK2 ANK3 POTED ANKRD27 POTEC ASAP2 ANKRA2 ANKDD1B ANKRD17 TNKS2 ANKFN1 | 7.28e-07 | 253 | 146 | 12 | PS50088 |
| Domain | ANK_REP_REGION | POTEB3 ANK2 ANK3 POTED ANKRD27 POTEC ASAP2 ANKRA2 ANKDD1B ANKRD17 TNKS2 ANKFN1 | 7.59e-07 | 254 | 146 | 12 | PS50297 |
| Domain | Ankyrin_rpt | POTEB3 ANK2 ANK3 POTED ANKRD27 POTEC ASAP2 ANKRA2 ANKDD1B ANKRD17 TNKS2 ANKFN1 | 1.05e-06 | 262 | 146 | 12 | IPR002110 |
| Domain | - | POTEB3 ANK2 ANK3 ANKRD27 POTEC ASAP2 ANKRA2 ANKDD1B ANKRD17 TNKS2 ANKFN1 | 4.10e-06 | 248 | 146 | 11 | 1.25.40.20 |
| Domain | Ankyrin_rpt-contain_dom | POTEB3 ANK2 ANK3 ANKRD27 POTEC ASAP2 ANKRA2 ANKDD1B ANKRD17 TNKS2 ANKFN1 | 5.15e-06 | 254 | 146 | 11 | IPR020683 |
| Domain | Ank_2 | POTEB3 ANK2 ANK3 ANKRD27 POTEC ASAP2 ANKRA2 ANKDD1B ANKRD17 TNKS2 | 7.52e-06 | 215 | 146 | 10 | PF12796 |
| Domain | - | 9.20e-06 | 6 | 146 | 3 | 3.90.1290.10 | |
| Domain | Plectin | 1.60e-05 | 7 | 146 | 3 | PF00681 | |
| Domain | Plectin_repeat | 1.60e-05 | 7 | 146 | 3 | IPR001101 | |
| Domain | PLEC | 1.60e-05 | 7 | 146 | 3 | SM00250 | |
| Domain | Ank | 7.81e-05 | 228 | 146 | 9 | PF00023 | |
| Domain | BAT2_N | 1.81e-04 | 3 | 146 | 2 | PF07001 | |
| Domain | BAT2_N | 1.81e-04 | 3 | 146 | 2 | IPR009738 | |
| Domain | PRRC2 | 1.81e-04 | 3 | 146 | 2 | IPR033184 | |
| Domain | Znf_FCS | 5.98e-04 | 5 | 146 | 2 | IPR012313 | |
| Domain | ACTININ_2 | 7.39e-04 | 23 | 146 | 3 | PS00020 | |
| Domain | ACTININ_1 | 7.39e-04 | 23 | 146 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 7.39e-04 | 23 | 146 | 3 | IPR001589 | |
| Domain | ZF_FCS | 8.92e-04 | 6 | 146 | 2 | PS51024 | |
| Domain | TB2_DP1_HVA22 | 8.92e-04 | 6 | 146 | 2 | IPR004345 | |
| Domain | TB2_DP1_HVA22 | 8.92e-04 | 6 | 146 | 2 | PF03134 | |
| Pubmed | PDE4B ILF3 OGT ANK2 ANK3 MYCBP2 UBR4 NUMA1 CAMSAP3 MPDZ SYNPO ITIH1 EMSY DST UBAP2L PRRC2C SPHKAP NAT10 IQSEC1 ANKRD17 DYNC1H1 CUX1 PRRC2B KIF2C | 2.83e-12 | 963 | 147 | 24 | 28671696 | |
| Pubmed | SMG1 SP2 OGT ATRX SCAF8 BICRA UBR4 NUMA1 POU2F1 PROSER1 RREB1 EMSY RIF1 DST SALL1 UBN1 UBAP2L PRRC2C ARFGAP1 NAT10 ANKRD17 EIF3H DOT1L DYNC1H1 CUX1 PRRC2B | 3.20e-10 | 1429 | 147 | 26 | 35140242 | |
| Pubmed | USP34 EPPK1 MYCBP2 ACAT1 UBR4 NUMA1 LCP1 TRIP12 RIF1 DST UBAP2L PRRC2C TLN1 NAT10 ANKRD17 NNT DYNC1H1 PRRC2B | 3.82e-10 | 653 | 147 | 18 | 22586326 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | ILF3 OGT SCAF8 NUMA1 SALL4 RIF1 SALL1 UBAP2L ANKRD17 DYNC1H1 PRRC2B | 1.21e-09 | 203 | 147 | 11 | 22083510 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ILF3 ATRX MYCBP2 SCAF8 NELFA NUMA1 CAMSAP3 POU2F1 RREB1 TRIP12 EMSY PHC2 RIF1 UBN1 UBAP2L ARFGAP1 IQSEC1 ANKRD17 | 5.49e-09 | 774 | 147 | 18 | 15302935 |
| Pubmed | TRPM6 USP34 PDE4B OGT ANK3 ATRX FAM210A SALL4 IRGQ TRIP12 PSME4 CELF1 UBAP2L ARFGAP1 NAT10 ANKRD17 HSD3B2 EIF2AK4 DOT1L ULK2 KIF2C | 6.65e-09 | 1084 | 147 | 21 | 11544199 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 EPPK1 MYCBP2 BICRA UBR4 LAMA5 IDUA NUBPL PHC2 DST PSME4 CELSR3 UBN1 TLN1 DISP2 DOT1L MBD5 DOCK6 ULK2 DYNC1H1 PRRC2B | 9.27e-09 | 1105 | 147 | 21 | 35748872 |
| Pubmed | OGT ANK3 MYCBP2 NUMA1 MPDZ EMSY UBAP2L PRRC2C TLN1 ARFGAP1 NAT10 DOT1L DYNC1H1 CUX1 PRRC2B | 1.36e-08 | 549 | 147 | 15 | 38280479 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | CPNE8 NUMA1 SALL4 PTBP1 TRIP12 UBAP2L PRRC2C ANKRD17 EIF2AK4 DOCK6 | 1.66e-08 | 202 | 147 | 10 | 33005030 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 ATRX UBR4 NUMA1 PTBP1 RREB1 RIF1 UBAP2L TLN1 NAT10 DYNC1H1 KIF2C | 1.99e-08 | 332 | 147 | 12 | 32786267 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | EPPK1 ANK3 BICRA UBR4 NUMA1 TRIP12 ASAP2 USF3 SALL1 UBN1 ANKRA2 TLN1 DYNC1H1 | 4.10e-08 | 430 | 147 | 13 | 35044719 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ANK3 MYCBP2 ABCA13 UBR4 TRIP12 LINS1 CELSR3 PRRC2C MTBP DNAH9 PRRC2B TNS3 | 4.98e-08 | 361 | 147 | 12 | 26167880 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCP110 MYCBP2 WWP2 CAMSAP3 MPDZ TRIP12 REEP2 ANKRD27 DST PRRC2C ARFGAP1 IQSEC1 ANKRD17 REEP4 DOCK6 TNS3 KIF2C | 1.57e-07 | 861 | 147 | 17 | 36931259 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | OGT ATRX NUMA1 POU2F1 SYNPO RREB1 TRIP12 EMSY PHC1 RIF1 UBN1 NAT10 DOT1L CUX1 | 3.40e-07 | 608 | 147 | 14 | 36089195 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ILF3 MYCBP2 ACAT1 TRIP12 CELF1 CELF2 UBAP2L PRRC2C TLN1 NAT10 ANKRD17 EIF3H NNT PRRC2B TNS3 | 4.83e-07 | 724 | 147 | 15 | 36232890 |
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 15830352 | ||
| Pubmed | 7.43e-07 | 304 | 147 | 10 | 32235678 | ||
| Pubmed | SMG1 OGT ATRX SCAF8 CAMSAP3 OBSL1 MPDZ ANKRD27 DST PSME4 PRRC2C ANKRD17 EIF2AK4 PRRC2B | 7.51e-07 | 650 | 147 | 14 | 38777146 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SP2 ILF3 OGT ACAT1 SCAF8 UBR4 NUMA1 PTBP1 RREB1 LCP1 TRIP12 ANKRD27 EMSY CELF1 CELF2 UBAP2L NAT10 IQSEC1 DYNC1H1 KIF2C | 7.86e-07 | 1318 | 147 | 20 | 30463901 |
| Pubmed | ILF3 OGT MYCBP2 NELFA BICRA POU2F1 PTBP1 RREB1 LCP1 EMSY CELF1 CELF2 PRRC2C TLN1 DYNC1H1 CUX1 PRRC2B KIF2C | 1.06e-06 | 1103 | 147 | 18 | 34189442 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ILF3 MYCBP2 ACAT1 UBR4 NUMA1 PTBP1 TRIP12 ANKRD27 RIF1 DST PSME4 UBN1 TLN1 NAT10 IQSEC1 ANKRD17 PRR14L DYNC1H1 TNS3 KIF2C | 1.18e-06 | 1353 | 147 | 20 | 29467282 |
| Pubmed | USP34 UBR4 MPDZ SLC30A1 TRIP12 DST PSME4 UBAP2L TLN1 DYNC1H1 | 1.25e-06 | 322 | 147 | 10 | 26514267 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | OGT ANK3 ATRX MYCBP2 TSHZ2 SCAF8 BICRA WWP2 CAMSAP3 PAM16 SLITRK3 SYNPO ASAP2 USF3 UBAP2L NAT10 ANKRD17 EIF2AK4 MBD5 DOCK6 CUX1 | 1.31e-06 | 1489 | 147 | 21 | 28611215 |
| Pubmed | CPNE8 ILF3 ANK2 WWP2 NUMA1 OBSL1 PTBP1 NUBPL TRIP12 PHC2 RIF1 UBAP2L PRRC2C TLN1 NAT10 IQSEC1 ANKRD17 EIF2AK4 DYNC1H1 PRRC2B | 1.44e-06 | 1371 | 147 | 20 | 36244648 | |
| Pubmed | SMG1 ANK3 ATRX MYCBP2 WWP2 UBR4 LAMA5 TRIP12 ANKRD27 DST ZNF76 TNKS2 DYNC1H1 | 1.51e-06 | 591 | 147 | 13 | 15231748 | |
| Pubmed | USP34 OGT MYCBP2 UBR4 CAMSAP3 RREB1 PHC1 DST SALL1 ANKRD17 CUX1 | 1.82e-06 | 418 | 147 | 11 | 34709266 | |
| Pubmed | ILF3 ANK2 ANK3 NUMA1 MPDZ SLC30A1 DST UBAP2L PRRC2C TLN1 ARFGAP1 ANKRD17 DYNC1H1 KIF2C | 2.04e-06 | 708 | 147 | 14 | 39231216 | |
| Pubmed | ILF3 OGT NELFA WWP2 NUMA1 PTBP1 UBAP2L PRRC2C NAT10 ANKRD17 EIF3H PRRC2B KIF2C | 2.33e-06 | 615 | 147 | 13 | 31048545 | |
| Pubmed | ILF3 MYCBP2 WWP2 UBR4 PTBP1 ANKRD27 CELF1 PRRC2C NAT10 IQSEC1 ANKRD17 NCEH1 EIF3H ARHGAP45 NNT PIGO DYNC1H1 KIF2C | 2.37e-06 | 1168 | 147 | 18 | 19946888 | |
| Pubmed | ANK2 MYCBP2 CAMSAP3 SYNPO XKR4 DST UBAP2L ARFGAP1 IQSEC1 ATP2B2 | 2.44e-06 | 347 | 147 | 10 | 17114649 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP2 ILF3 OGT ATRX NUMA1 PAM16 PTBP1 RREB1 TRIP12 EMSY PHC2 RIF1 DST UBN1 CELF1 NAT10 REEP4 CUX1 KIF2C | 2.46e-06 | 1294 | 147 | 19 | 30804502 |
| Pubmed | 2.58e-06 | 272 | 147 | 9 | 31010829 | ||
| Pubmed | USP34 SMG1 CRLF1 BICRA POTED CAMSAP3 ITIH1 PHC1 PSME4 TLE2 GRIN3A REEP4 ARHGAP45 ATP2B2 KIF2C | 2.69e-06 | 832 | 147 | 15 | 36724073 | |
| Pubmed | USP34 SMG1 LAMA5 SYNPO ANKRD27 DST PSME4 CELSR3 NAT10 ANKRD17 EIF2AK4 DOCK6 | 2.83e-06 | 529 | 147 | 12 | 14621295 | |
| Pubmed | USP34 SMG1 CPNE8 HDHD5 UBR4 NUMA1 SYNPO PTBP1 NUBPL DST UBN1 UBAP2L PRRC2C TLN1 ARFGAP1 NAT10 EIF3H DYNC1H1 CUX1 PRRC2B | 3.02e-06 | 1440 | 147 | 20 | 30833792 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ATRX NELFA BICRA NUMA1 TRIP12 PHC1 PHC2 RIF1 NAT10 ARHGAP45 DYNC1H1 KIF2C | 3.06e-06 | 533 | 147 | 12 | 30554943 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ILF3 ATRX ACAT1 BICRA NUMA1 PTBP1 RREB1 TRIP12 EMSY RIF1 SALL1 UBN1 UBAP2L PRRC2C NAT10 CUX1 | 3.10e-06 | 954 | 147 | 16 | 36373674 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SP2 ILF3 NELFA SYNPO EMSY SALL1 UBN1 CELF1 UBAP2L TLN1 ARFGAP1 | 3.24e-06 | 444 | 147 | 11 | 34795231 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CCP110 OGT ANK3 ATRX MYCBP2 FAM210A CAMSAP3 OBSL1 PAM16 RREB1 IFT43 RIF1 ASAP2 KIF3C REEP4 ATP2B2 DYNC1H1 PRRC2B KIF2C | 3.31e-06 | 1321 | 147 | 19 | 27173435 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 3.60e-06 | 212 | 147 | 8 | 33853758 | |
| Pubmed | 4.08e-06 | 8 | 147 | 3 | 12475935 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 4.23e-06 | 153 | 147 | 7 | 26365490 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 ILF3 ATRX SCAF8 PTBP1 TRIP12 RIF1 UBN1 TLN1 NAT10 DYNC1H1 KIF2C | 7.45e-06 | 582 | 147 | 12 | 20467437 |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 7.52e-06 | 167 | 147 | 7 | 20362541 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CPNE8 EPPK1 ILF3 MYCBP2 ACAT1 NUMA1 OBSL1 PTBP1 TRIP12 RIF1 DST UBAP2L TLN1 NAT10 NNT DYNC1H1 | 7.54e-06 | 1024 | 147 | 16 | 24711643 |
| Pubmed | 7.62e-06 | 486 | 147 | 11 | 20936779 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPPK1 ILF3 OGT ANK3 MYCBP2 UBR4 CAMSAP3 MPDZ PTBP1 LCP1 DST UBAP2L PRRC2C TLN1 ANKRD17 EIF3H DYNC1H1 | 7.85e-06 | 1149 | 147 | 17 | 35446349 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 CCP110 OGT ATRX OBSL1 EMSY SALL1 UBN1 PRRC2C DOT1L PRRC2B KIF2C | 8.25e-06 | 588 | 147 | 12 | 38580884 |
| Pubmed | 8.31e-06 | 399 | 147 | 10 | 35987950 | ||
| Pubmed | ILF3 ACAT1 UBR4 PTBP1 UBAP2L PRRC2C TLN1 NAT10 ANKRD17 DYNC1H1 VCAM1 | 8.38e-06 | 491 | 147 | 11 | 22623428 | |
| Pubmed | 8.48e-06 | 65 | 147 | 5 | 22496869 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SMG1 UBR4 SARM1 NUMA1 PTBP1 TRIP12 DST CELF1 CELF2 UBAP2L NAT10 | 9.57e-06 | 498 | 147 | 11 | 36634849 |
| Pubmed | SCAF8 OBSL1 UBAP2L PRRC2C SPHKAP TLN1 DISP2 ULK2 DYNC1H1 PRRC2B | 9.87e-06 | 407 | 147 | 10 | 12693553 | |
| Pubmed | 1.04e-05 | 116 | 147 | 6 | 21282530 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ILF3 ANK2 ATRX NUMA1 EMSY RIF1 DST UBAP2L PRRC2C TLN1 ARFGAP1 NAT10 ANKRD17 PRR14L PRRC2B | 1.07e-05 | 934 | 147 | 15 | 33916271 |
| Pubmed | 1.28e-05 | 332 | 147 | 9 | 37433992 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.43e-05 | 256 | 147 | 8 | 33397691 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | OGT UBR4 OBSL1 POU2F1 TRIP12 EMSY FOXD3 RIF1 SALL1 PRRC2C ANKRD17 DYNC1H1 CUX1 KIF2C | 1.77e-05 | 857 | 147 | 14 | 25609649 |
| Pubmed | Transcription Factor SP2 Enhanced the Expression of Cd14 in Colitis-Susceptible C3H/HeJBir. | 1.77e-05 | 2 | 147 | 2 | 27191968 | |
| Pubmed | Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. | 1.77e-05 | 2 | 147 | 2 | 19476507 | |
| Pubmed | Characterization of interleukin 2 stimulated 65-kilodalton phosphoprotein in human T cells. | 1.77e-05 | 2 | 147 | 2 | 2111166 | |
| Pubmed | Identification of I-plastin, a human fimbrin isoform expressed in intestine and kidney. | 1.77e-05 | 2 | 147 | 2 | 8139549 | |
| Pubmed | NuMA1 promotes axon initial segment assembly through inhibition of endocytosis. | 1.77e-05 | 2 | 147 | 2 | 31727776 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 8628397 | ||
| Pubmed | Isolation and expression of Napor/CUG-BP2 in embryo development. | 1.77e-05 | 2 | 147 | 2 | 12763013 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21541285 | ||
| Pubmed | Deregulation of pancreas-specific oxidoreductin ERO1β in the pathogenesis of diabetes mellitus. | 1.77e-05 | 2 | 147 | 2 | 24469402 | |
| Pubmed | NuMA recruits dynein activity to microtubule minus-ends at mitosis. | 1.77e-05 | 2 | 147 | 2 | 29185983 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 23468433 | ||
| Pubmed | Aqp2-expressing cells give rise to renal intercalated cells. | 1.77e-05 | 2 | 147 | 2 | 23308014 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 12395297 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 33074857 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 19350679 | ||
| Pubmed | Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. | 1.77e-05 | 2 | 147 | 2 | 21282364 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 11781319 | ||
| Pubmed | Structural basis of diverse membrane target recognitions by ankyrins. | 1.77e-05 | 2 | 147 | 2 | 25383926 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 31375680 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 17295837 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24595139 | ||
| Pubmed | 1.99e-05 | 130 | 147 | 6 | 12421765 | ||
| Pubmed | ILF3 OGT UBR4 CAMSAP3 PTBP1 RIF1 UBAP2L PRRC2C NAT10 PRRC2B KIF2C | 2.43e-05 | 551 | 147 | 11 | 34728620 | |
| Pubmed | 3.00e-05 | 284 | 147 | 8 | 29459677 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.10e-05 | 208 | 147 | 7 | 33230847 | |
| Pubmed | NUMA1 SLC30A1 DST UBAP2L PRRC2C SCARA5 TLN1 ARFGAP1 PRR14L REEP4 CUX1 | 3.21e-05 | 568 | 147 | 11 | 37774976 | |
| Pubmed | CCP110 ATRX NUMA1 OBSL1 SALL4 TRIP12 CELF1 UBAP2L PRRC2C EIF3H | 3.31e-05 | 469 | 147 | 10 | 27634302 | |
| Pubmed | SMG1 ILF3 ANK2 ATRX UBR4 NUMA1 CAMSAP3 SYNPO PTBP1 LCP1 TRIP12 DST PRRC2C EIF2AK4 ATP2B2 PLS1 CUX1 PRRC2B | 4.03e-05 | 1442 | 147 | 18 | 35575683 | |
| Pubmed | 4.63e-05 | 151 | 147 | 6 | 17043677 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | CA12 USP34 ACAT1 BICRA HDHD5 WWP2 SARM1 NUBPL SLC30A1 RIF1 SCARA5 NCEH1 DOCK6 PIGO CUX1 | 4.65e-05 | 1061 | 147 | 15 | 33845483 |
| Pubmed | 4.69e-05 | 222 | 147 | 7 | 37071664 | ||
| Pubmed | ILF3 OGT ATRX NELFA BICRA UBR4 POU2F1 EMSY SLC39A8 LINS1 SALL1 UBN1 ANKRD17 MTBP EIF2AK4 REEP4 ULK2 | 4.87e-05 | 1327 | 147 | 17 | 32694731 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 4.89e-05 | 394 | 147 | 9 | 27248496 | |
| Pubmed | ILF3 ACAT1 UBR4 PTBP1 LCP1 CELF2 UBAP2L TLN1 NAT10 DYNC1H1 VCAM1 KIF2C | 5.01e-05 | 707 | 147 | 12 | 19738201 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CPNE8 NAAA ACAT1 WWP2 LAMA5 LCP1 IDUA AQP2 ITIH1 SPPL2A CD14 TLN1 C7 DYNC1H1 VCAM1 | 5.11e-05 | 1070 | 147 | 15 | 23533145 |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 19440552 | ||
| Pubmed | The genetic basis of adrenal gland weight and structure in BXD recombinant inbred mice. | 5.31e-05 | 3 | 147 | 2 | 21347846 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 7655078 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 28694070 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 15611082 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 8428952 | ||
| Pubmed | Aqp5 is a new transcriptional target of Dot1a and a regulator of Aqp2. | 5.31e-05 | 3 | 147 | 2 | 23326416 | |
| Interaction | POU5F1 interactions | USP34 ILF3 OGT SCAF8 HDHD5 WWP2 UBR4 NUMA1 SALL4 EMSY PHC1 FOXD3 RIF1 SALL1 UBAP2L ANKRD17 DYNC1H1 PRRC2B | 2.19e-07 | 584 | 145 | 18 | int:POU5F1 |
| Interaction | DAZL interactions | 1.06e-06 | 145 | 145 | 9 | int:DAZL | |
| Interaction | POTED interactions | 1.45e-06 | 4 | 145 | 3 | int:POTED | |
| Interaction | LRRC31 interactions | CPNE8 NUMA1 SALL4 PTBP1 TRIP12 UBAP2L PRRC2C ANKRD17 EIF2AK4 DOCK6 | 2.38e-06 | 205 | 145 | 10 | int:LRRC31 |
| Interaction | LSM14A interactions | SMG1 ILF3 OGT MYCBP2 CELF1 UBAP2L PRRC2C ANKRD17 DOT1L PRRC2B KIF2C | 2.94e-06 | 260 | 145 | 11 | int:LSM14A |
| Interaction | BMI1 interactions | ILF3 OGT ATRX SCAF8 NUMA1 EVPL PTBP1 PHC1 PHC2 DST CELF1 UBAP2L PRRC2C NAT10 EIF3H DYNC1H1 PRRC2B | 5.44e-06 | 659 | 145 | 17 | int:BMI1 |
| Interaction | SUMO2 interactions | EPPK1 ATRX UBR4 NUMA1 PTBP1 RREB1 TRIP12 RIF1 DST SALL1 UBAP2L TLN1 NAT10 DYNC1H1 CUX1 KIF2C | 5.73e-06 | 591 | 145 | 16 | int:SUMO2 |
| Interaction | MTNR1B interactions | 6.07e-06 | 135 | 145 | 8 | int:MTNR1B | |
| Interaction | SIRT7 interactions | USP34 EPPK1 MYCBP2 ACAT1 UBR4 NUMA1 LCP1 TRIP12 RIF1 DST UBAP2L PRRC2C TLN1 NAT10 ANKRD17 NNT DYNC1H1 PRRC2B | 6.84e-06 | 744 | 145 | 18 | int:SIRT7 |
| Interaction | TFCP2L1 interactions | 7.40e-06 | 99 | 145 | 7 | int:TFCP2L1 | |
| Interaction | FMR1 interactions | SMG1 ILF3 MYCBP2 WWP2 UBR4 NUMA1 EMSY UBAP2L PRRC2C IQSEC1 ANKRD17 DOT1L DYNC1H1 CUX1 PRRC2B | 7.71e-06 | 536 | 145 | 15 | int:FMR1 |
| Interaction | PPP1R12B interactions | 9.48e-06 | 68 | 145 | 6 | int:PPP1R12B | |
| Interaction | IGF2BP2 interactions | SMG1 CCP110 ILF3 OGT WWP2 PTBP1 CELF1 CELF2 UBAP2L PRRC2C DOT1L PRRC2B | 1.09e-05 | 357 | 145 | 12 | int:IGF2BP2 |
| Interaction | ASF1A interactions | 1.33e-05 | 249 | 145 | 10 | int:ASF1A | |
| Interaction | KCNA3 interactions | EPPK1 ILF3 ANK2 ANK3 ABCA13 NUMA1 MPDZ PTBP1 SLC30A1 ASAP2 DST UBAP2L PRRC2C TLN1 ARFGAP1 ANKRD17 EIF2AK4 DYNC1H1 KIF2C | 1.61e-05 | 871 | 145 | 19 | int:KCNA3 |
| Interaction | FEV interactions | 1.66e-05 | 203 | 145 | 9 | int:FEV | |
| Interaction | MTNR1A interactions | 2.74e-05 | 166 | 145 | 8 | int:MTNR1A | |
| Interaction | SPATS2L interactions | 3.95e-05 | 128 | 145 | 7 | int:SPATS2L | |
| Interaction | CELF1 interactions | ILF3 OGT SCAF8 CAMSAP3 PTBP1 CELF1 CELF2 UBAP2L PRRC2C PRRC2B | 4.59e-05 | 288 | 145 | 10 | int:CELF1 |
| Interaction | FUBP3 interactions | OGT OBSL1 CELF1 CELF2 UBAP2L PRRC2C ANKRD17 DOT1L VCAM1 PRRC2B | 5.95e-05 | 297 | 145 | 10 | int:FUBP3 |
| Interaction | UBAP2L interactions | ACAT1 WWP2 OBSL1 CELF1 CELF2 UBAP2L PRRC2C ANKRD17 VCAM1 PRRC2B | 6.11e-05 | 298 | 145 | 10 | int:UBAP2L |
| Interaction | DDX3X interactions | UBL7 SMG1 EPPK1 ILF3 OGT MYCBP2 WWP2 OBSL1 PSME4 PRRC2C EIF3H DOT1L MBD5 VCAM1 PRRC2B | 7.28e-05 | 651 | 145 | 15 | int:DDX3X |
| Interaction | POTEC interactions | 9.90e-05 | 13 | 145 | 3 | int:POTEC | |
| Interaction | TOP2A interactions | ILF3 WWP2 NUMA1 OBSL1 FOXD3 PRRC2C TLE2 HSD3B2 EIF3H DOT1L MBD5 DYNC1H1 VCAM1 | 1.01e-04 | 520 | 145 | 13 | int:TOP2A |
| Interaction | SHMT2 interactions | CCP110 CPNE8 ILF3 OGT CRLF1 SCAF8 FAM210A UBR4 OBSL1 MPDZ UBAP2L TLN1 ZNF76 NNT NLRP13 | 1.02e-04 | 671 | 145 | 15 | int:SHMT2 |
| Interaction | RNF214 interactions | 1.06e-04 | 104 | 145 | 6 | int:RNF214 | |
| Interaction | MEX3A interactions | EPPK1 NUMA1 DST UBN1 CELF1 UBAP2L PRRC2C TLN1 DYNC1H1 PRRC2B TNS3 | 1.08e-04 | 384 | 145 | 11 | int:MEX3A |
| Interaction | POTEB3 interactions | 1.13e-04 | 35 | 145 | 4 | int:POTEB3 | |
| Interaction | TEDC2 interactions | 1.25e-04 | 206 | 145 | 8 | int:TEDC2 | |
| Interaction | TOP3B interactions | USP34 EPPK1 MYCBP2 BICRA UBR4 LAMA5 IDUA NUBPL PHC2 DST PSME4 CELSR3 UBN1 CELF1 UBAP2L TLN1 ANKRD17 DISP2 DOT1L MBD5 DOCK6 ULK2 DYNC1H1 PRRC2B | 1.29e-04 | 1470 | 145 | 24 | int:TOP3B |
| Interaction | CDC5L interactions | EPPK1 ILF3 OGT SCAF8 WWP2 OBSL1 SYNPO PTBP1 RIF1 DST UBN1 TLN1 NAT10 KIF3C DOT1L DYNC1H1 KIF2C | 1.44e-04 | 855 | 145 | 17 | int:CDC5L |
| Interaction | MOV10 interactions | SMG1 CCP110 CPNE8 PDE4B ILF3 CRLF1 SCAF8 WWP2 UBR4 NUMA1 SYNPO PTBP1 EMSY CELF1 CELF2 PRRC2C TLN1 ZNF76 DOT1L PRRC2B TNS3 KIF2C | 1.48e-04 | 1297 | 145 | 22 | int:MOV10 |
| Interaction | TRIP12 interactions | 1.63e-04 | 214 | 145 | 8 | int:TRIP12 | |
| Interaction | UNK interactions | USP34 SMG1 OGT ACAT1 DST UBAP2L PRRC2C ANKRD17 EIF3H DYNC1H1 PRRC2B | 1.83e-04 | 408 | 145 | 11 | int:UNK |
| Interaction | NR0B1 interactions | 1.92e-04 | 40 | 145 | 4 | int:NR0B1 | |
| Interaction | SOX2 interactions | USP34 SP2 ILF3 OGT ACAT1 WWP2 UBR4 NUMA1 POU2F1 EVPL SALL4 PROSER1 PTBP1 LCP1 TRIP12 ITIH1 PHC2 SALL1 NAT10 ANKRD17 PLS1 CUX1 PRRC2B | 2.07e-04 | 1422 | 145 | 23 | int:SOX2 |
| Interaction | C1orf54 interactions | 2.10e-04 | 167 | 145 | 7 | int:C1orf54 | |
| Interaction | WWTR1 interactions | OGT ANK3 MYCBP2 NUMA1 MPDZ EMSY PRRC2C TLN1 ARFGAP1 CUX1 PRRC2B | 2.45e-04 | 422 | 145 | 11 | int:WWTR1 |
| Interaction | SHANK3 interactions | ANK2 ANK3 ACAT1 NUMA1 SYNPO PTBP1 SLC30A1 ITIH1 IQSEC1 ATP2B2 DYNC1H1 LRRC73 | 2.53e-04 | 496 | 145 | 12 | int:SHANK3 |
| Interaction | EIF4A1 interactions | 2.55e-04 | 355 | 145 | 10 | int:EIF4A1 | |
| Interaction | GGNBP2 interactions | 2.75e-04 | 18 | 145 | 3 | int:GGNBP2 | |
| Interaction | H4C11 interactions | 3.05e-04 | 45 | 145 | 4 | int:H4C11 | |
| Interaction | RNU5B-1 interactions | 3.06e-04 | 4 | 145 | 2 | int:RNU5B-1 | |
| Interaction | IGF2BP1 interactions | SMG1 ILF3 OGT WWP2 OBSL1 PTBP1 CELF1 CELF2 PRRC2C NCEH1 VCAM1 PRRC2B | 3.15e-04 | 508 | 145 | 12 | int:IGF2BP1 |
| Interaction | OTUD4 interactions | 3.16e-04 | 236 | 145 | 8 | int:OTUD4 | |
| Interaction | RPS20 interactions | PDE4B ILF3 WWP2 NUMA1 UBAP2L PRRC2C ANKRD17 EIF3H DOT1L DYNC1H1 VCAM1 PRRC2B | 3.44e-04 | 513 | 145 | 12 | int:RPS20 |
| Interaction | G3BP1 interactions | EPPK1 OGT MYCBP2 WWP2 OBSL1 PTBP1 DST CELF1 UBAP2L PRRC2C ANKRD17 EIF3H DOT1L DYNC1H1 VCAM1 PRRC2B | 3.44e-04 | 835 | 145 | 16 | int:G3BP1 |
| Interaction | SMG5 interactions | 3.52e-04 | 84 | 145 | 5 | int:SMG5 | |
| Interaction | WDR5 interactions | EPPK1 ILF3 OGT ACAT1 WWP2 UBR4 SALL4 PTBP1 SLC30A1 UBAP2L PRRC2C TLN1 ARFGAP1 NAT10 IQSEC1 DOT1L MBD5 DYNC1H1 KIF2C | 3.53e-04 | 1101 | 145 | 19 | int:WDR5 |
| Interaction | YWHAH interactions | CCP110 EPPK1 ILF3 OGT MYCBP2 CAMSAP3 MPDZ TRIP12 REEP2 ANKRD27 DST PRRC2C ARFGAP1 ANKRD17 MTBP REEP4 DOCK6 TNS3 KIF2C | 3.57e-04 | 1102 | 145 | 19 | int:YWHAH |
| Interaction | SF1 interactions | 3.63e-04 | 304 | 145 | 9 | int:SF1 | |
| Interaction | KIF2A interactions | 3.74e-04 | 242 | 145 | 8 | int:KIF2A | |
| Interaction | G3BP2 interactions | PDE4B ILF3 OGT MYCBP2 WWP2 OBSL1 CELF1 UBAP2L PRRC2C EIF3H DOT1L PRRC2B | 3.75e-04 | 518 | 145 | 12 | int:G3BP2 |
| Interaction | GGH interactions | 3.84e-04 | 243 | 145 | 8 | int:GGH | |
| Interaction | ITGB2 interactions | 3.89e-04 | 132 | 145 | 6 | int:ITGB2 | |
| Interaction | RABGGTA interactions | 3.92e-04 | 86 | 145 | 5 | int:RABGGTA | |
| GeneFamily | Ankyrin repeat domain containing | ANK2 ANK3 POTED ANKRD27 POTEC ASAP2 ANKRA2 ANKDD1B ANKRD17 TNKS2 ANKFN1 | 9.78e-08 | 242 | 100 | 11 | 403 |
| GeneFamily | EF-hand domain containing|Plakins | 9.01e-06 | 8 | 100 | 3 | 939 | |
| GeneFamily | Receptor accessory proteins | 4.48e-04 | 6 | 100 | 2 | 717 | |
| GeneFamily | Sterile alpha motif domain containing | 1.44e-03 | 88 | 100 | 4 | 760 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 2.27e-03 | 13 | 100 | 2 | 685 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 1.44e-05 | 194 | 147 | 8 | M8864 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 1.74e-05 | 199 | 147 | 8 | M7596 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.80e-05 | 200 | 147 | 8 | M9889 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | SMG1 ILF3 OGT ERO1B ANK3 MYCBP2 OBSL1 PRRC2C NCEH1 TNKS2 CUX1 | 1.74e-06 | 261 | 144 | 11 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | SMG1 ILF3 OGT ANK3 MYCBP2 SALL4 CELF1 GRIN3A TNKS2 CUX1 PRRC2B | 9.55e-06 | 312 | 144 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | USP34 RBM44 NAAA ERO1B ATRX CHDH CAMSAP3 SALL4 SYNPO LCP1 CHM RIF1 UBAP2L PRRC2C WEE2 HSD3B2 PLS1 | 1.91e-05 | 770 | 144 | 17 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | SMG1 ILF3 OGT ERO1B ANK3 MYCBP2 WWP2 CAMSAP3 OBSL1 LAMA5 LINS1 PRRC2C TLE2 CRACDL NCEH1 TNKS2 CUX1 | 2.47e-05 | 786 | 144 | 17 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | CA12 CCP110 CAMSAP3 LAMA5 POU2F1 SALL4 REEP2 DST SALL1 CELF2 PALM3 ATP2B2 PLS1 | 3.36e-05 | 495 | 144 | 13 | Facebase_RNAseq_e8.5_Floor Plate_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.49e-05 | 182 | 144 | 8 | gudmap_developingGonad_e16.5_ovary_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.64e-05 | 91 | 144 | 6 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | CA12 OGT CRLF1 ATRX MPDZ POU2F1 SALL4 SYNPO LCP1 IFT43 EMSY SLC39A8 USF3 UBN1 PALM3 ZNF76 MBD5 PIGO VCAM1 | 3.86e-05 | 985 | 144 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | SMG1 OGT ANK2 ATRX MYCBP2 FAM210A SALL4 SLC39A8 RIF1 SPPL2A SALL1 CELF1 PRRC2C DISP2 GRIN3A TNKS2 CUX1 | 4.08e-05 | 818 | 144 | 17 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | SMG1 OGT ANK3 ATRX MYCBP2 TRIP12 SLC39A8 PRRC2C NCEH1 TNKS2 CUX1 | 5.18e-05 | 375 | 144 | 11 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | SMG1 ILF3 OGT ANK3 ATRX MYCBP2 ABCA13 PRRC2C NCEH1 TNKS2 CUX1 | 5.70e-05 | 379 | 144 | 11 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 7.03e-05 | 201 | 144 | 8 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.76e-05 | 330 | 144 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | ILF3 ANK3 ATRX MYCBP2 ABCA13 SALL1 PRRC2C NCEH1 HSD3B2 TNKS2 CUX1 | 9.62e-05 | 402 | 144 | 11 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.09e-04 | 339 | 144 | 10 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.22e-04 | 113 | 144 | 6 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CA12 CCP110 ANK2 ATRX POU2F1 SALL4 DCUN1D4 EMSY SLC39A8 PHC1 RIF1 PRDM9 SALL1 PSME4 NAT10 PALM3 ANKDD1B MTBP MBD5 ANKFN1 CUX1 VCAM1 KIF2C | 1.27e-04 | 1459 | 144 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | CA12 CCP110 SP2 SCAF8 BICRA CAMSAP3 LAMA5 POU2F1 SALL4 NUBPL REEP2 DST SALL1 CELF2 PRRC2C PALM3 ATP2B2 PLS1 | 1.39e-04 | 994 | 144 | 18 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_500 | 1.48e-04 | 117 | 144 | 6 | gudmap_developingKidney_e15.5_Medullary collecting duct_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 1.69e-04 | 41 | 144 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | ILF3 ANK3 ATRX MYCBP2 FAM210A TRIP12 SPPL2A CELF1 TNKS2 CUX1 | 2.17e-04 | 369 | 144 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | SMG1 OGT ANK3 ATRX MYCBP2 CHDH LAMA5 TRIP12 SLC39A8 SALL1 PRRC2C NCEH1 HSD3B2 TNKS2 CUX1 | 2.53e-04 | 774 | 144 | 15 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.69e-04 | 84 | 144 | 5 | gudmap_developingKidney_e15.5_Endothelial cells_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | CPNE8 ANK2 ANK3 WWP2 CAMSAP3 LAMA5 EVPL LCP1 DST ANKRA2 CRACDL GRIN3A TNKS2 PLS1 CUX1 | 2.75e-04 | 780 | 144 | 15 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | USP34 SMG1 RBM44 NAAA ERO1B ATRX OBSL1 CHM RIF1 SPPL2A UBN1 PRRC2C TLE2 ANKRD17 HSD3B2 | 3.36e-04 | 795 | 144 | 15 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | SMG1 ILF3 OGT ANK3 ATRX MYCBP2 ABCA13 WWP2 DST SALL1 PRRC2C NCEH1 HSD3B2 TNKS2 CUX1 | 3.36e-04 | 795 | 144 | 15 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | CA12 PDE4B NAAA CRLF1 ATRX TSHZ2 POU2F1 SALL4 SYNPO SLC39A8 PRDM9 TLE2 WEE2 ULK2 ATP2B2 PLS1 VCAM1 | 3.51e-04 | 979 | 144 | 17 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | SMG1 ILF3 OGT CRLF1 ANK3 ATRX CHDH LAMA5 SALL4 SLC39A8 RIF1 SALL1 PRRC2C TNKS2 CUX1 | 3.64e-04 | 801 | 144 | 15 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | ATRX POU2F1 PROSER1 PHC1 RIF1 DST PRRC2C PALM3 MTBP TNKS2 KIF2C | 3.64e-04 | 469 | 144 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CCP110 SP2 ANK2 ATRX LRFN3 IRGQ CHM DCUN1D4 REEP2 EMSY PHC1 PHC2 PRDM9 SALL1 PSME4 PALM3 ANKDD1B ANKFN1 PIGO CUX1 KIF2C | 3.75e-04 | 1370 | 144 | 21 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | SMG1 ILF3 OGT ANK3 MYCBP2 WWP2 SALL4 DST SALL1 CELF1 CRACDL GRIN3A TNKS2 CUX1 PRRC2B | 3.88e-04 | 806 | 144 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | UBL7 CPNE8 RBM44 OGT ATRX NELFA POU2F1 SALL4 PTBP1 RIF1 UBN1 UBAP2L SCARA5 HSD3B2 KIF2C | 4.59e-04 | 819 | 144 | 15 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_500 | 4.62e-04 | 406 | 144 | 10 | gudmap_developingKidney_e15.5_ureter tip_500_flank cortic collct | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.88e-04 | 146 | 144 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_100 | 5.23e-04 | 97 | 144 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | CA12 CRLF1 ATRX MPDZ POU2F1 SALL4 SYNPO LCP1 SLC39A8 PALM3 VCAM1 | 5.43e-04 | 492 | 144 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.63e-04 | 150 | 144 | 6 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.03e-04 | 152 | 144 | 6 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.03e-04 | 152 | 144 | 6 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.06e-04 | 57 | 144 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#5 | 6.91e-04 | 59 | 144 | 4 | Facebase_RNAseq_e8.5_Floor Plate_500_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 6.92e-04 | 156 | 144 | 6 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.12e-04 | 217 | 144 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | ILF3 OGT CRLF1 ERO1B SALL4 SYNPO SLC39A8 RIF1 DST SALL1 GRIN3A TNKS2 CUX1 VCAM1 | 7.56e-04 | 769 | 144 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 7.84e-04 | 61 | 144 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K5 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-08 | 195 | 147 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-07 | 195 | 147 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.48e-07 | 200 | 147 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-06 | 181 | 147 | 7 | e2d03115a87f45a7ddd3ade6b9ac3843639bd41a | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-06 | 181 | 147 | 7 | d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264 | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-06 | 185 | 147 | 7 | e583f6601f9ed79b0b23d2f9426a4ba8b969230b | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 3.32e-06 | 190 | 147 | 7 | ec0ab31266583a0966ac7615d5c0fabb7b7e66e8 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 191 | 147 | 7 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.21e-06 | 197 | 147 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.50e-06 | 199 | 147 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.50e-06 | 199 | 147 | 7 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.65e-06 | 200 | 147 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.11e-05 | 151 | 147 | 6 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.33e-05 | 156 | 147 | 6 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 158 | 147 | 6 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.90e-05 | 166 | 147 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 168 | 147 | 6 | b9db0b1e4fe54a1fe79530d15d206155a1bfac39 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 2.64e-05 | 176 | 147 | 6 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.81e-05 | 178 | 147 | 6 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.81e-05 | 178 | 147 | 6 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 179 | 147 | 6 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-05 | 180 | 147 | 6 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | COVID-19-kidney-Bcells|kidney / Disease (COVID-19 only), tissue and cell type | 2.99e-05 | 180 | 147 | 6 | 5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 180 | 147 | 6 | 65c069585737302a69b9a01476f4eb8b50cb2bfd | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.08e-05 | 181 | 147 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.28e-05 | 183 | 147 | 6 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 3.48e-05 | 185 | 147 | 6 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.59e-05 | 186 | 147 | 6 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.59e-05 | 186 | 147 | 6 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 187 | 147 | 6 | 8fa454dc4e6a3e8e2bb2ad803acc579e0d3f76da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-B_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 187 | 147 | 6 | edad646d5eb1d70b768dc21fe02ef5265214e8e6 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 189 | 147 | 6 | b491204cf38dc80a2583e3082a82dda8d77b3fc4 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 4.04e-05 | 190 | 147 | 6 | 96c6078619e85f630c9754aca5d6066433e22836 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-05 | 190 | 147 | 6 | aaf5f1c1ff7b1454f4e5dacfeb48e1c3627e3372 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-05 | 190 | 147 | 6 | a20123d5c6cb8c2f0dfd99bbfdb571a73c36234d | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 4.29e-05 | 192 | 147 | 6 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.29e-05 | 192 | 147 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.29e-05 | 192 | 147 | 6 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|(1)_Control_(PBS) / Stress and Cell class | 4.29e-05 | 192 | 147 | 6 | 40f380f5f0bed63a7404be050838ebd01ef08987 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 4.29e-05 | 192 | 147 | 6 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 192 | 147 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.41e-05 | 193 | 147 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 193 | 147 | 6 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 193 | 147 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 193 | 147 | 6 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 194 | 147 | 6 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 194 | 147 | 6 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.67e-05 | 195 | 147 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 4.67e-05 | 195 | 147 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 195 | 147 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-05 | 195 | 147 | 6 | ce8215d503cad3a9bc7d5d2be4adb57408015593 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.67e-05 | 195 | 147 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | ILEUM-non-inflamed-(9)_Enteric_neurons|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.81e-05 | 196 | 147 | 6 | 998aa523555ed6bc9c1b5cacbf7ba77c7b218e6b | |
| ToppCell | ILEUM-non-inflamed-(9)_Neuro_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.81e-05 | 196 | 147 | 6 | 2b08cd6730119d5dea0152709ab8de580b66cd3c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-05 | 196 | 147 | 6 | 97ac47daf5bb07fa5dda3976e1ae402750f959b5 | |
| ToppCell | (7)_Macrophage|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.81e-05 | 196 | 147 | 6 | f1c822860d2a0bae84b0263b0151185756423e0f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 197 | 147 | 6 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.95e-05 | 197 | 147 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.95e-05 | 197 | 147 | 6 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.95e-05 | 197 | 147 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 5.09e-05 | 198 | 147 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 199 | 147 | 6 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-05 | 199 | 147 | 6 | f4fdf94c561dca35bb17766d908c5030655f43eb | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-05 | 199 | 147 | 6 | c0fe99ed906d0eb99cccdab9a1fa32c17b3542e7 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.38e-05 | 200 | 147 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 5.38e-05 | 200 | 147 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.38e-05 | 200 | 147 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.74e-04 | 157 | 147 | 5 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-9|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.85e-04 | 159 | 147 | 5 | f376bf6cd0ed374211edac3c384f3a78f0caef2a | |
| ToppCell | Control-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.01e-04 | 162 | 147 | 5 | aa80452b972bb8ad3670ffaba4ce26fadb33b185 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.01e-04 | 162 | 147 | 5 | 7f9385aa749bfb2fa9fee6939fe46d946bc21d31 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 165 | 147 | 5 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 167 | 147 | 5 | 3dfec2fcc36caa6e394efae5e540a6fa28759977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 167 | 147 | 5 | 95b3b5ba3414729f0460a26a0deca48de0cbe33e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 167 | 147 | 5 | 9480739587d51e67a281778b9bddd7b5ffc3ad92 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.38e-04 | 168 | 147 | 5 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.45e-04 | 169 | 147 | 5 | 41cb92b0558f0d5a3e511058efd9110258b88ee3 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.45e-04 | 169 | 147 | 5 | 91f4b6a14708e701b2af22989004282041777491 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-04 | 169 | 147 | 5 | 2a35846b0e0be0a19a5a04a86cbd72ce65257c8a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.52e-04 | 170 | 147 | 5 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | droplet-Fat-Gat-18m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 170 | 147 | 5 | 5185187ecf26b4c9eaa0c01ad52697ab8d075cc7 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-04 | 170 | 147 | 5 | e08a6c5ac34c456da8c7318f104e06fca585be1f | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.58e-04 | 171 | 147 | 5 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 172 | 147 | 5 | a7eee0a30d2fe20c865a07b9004c6a821a72c0c4 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 172 | 147 | 5 | 0a9fe2cd28203970295a1288078c66eadac1c9ed | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 173 | 147 | 5 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 173 | 147 | 5 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 173 | 147 | 5 | 68bcc0eee15df9cf3516c641709154301bd7b38f | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 173 | 147 | 5 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 173 | 147 | 5 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 173 | 147 | 5 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.80e-04 | 174 | 147 | 5 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.80e-04 | 174 | 147 | 5 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-04 | 175 | 147 | 5 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.95e-04 | 176 | 147 | 5 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|COPD / Disease state, Lineage and Cell class | 2.95e-04 | 176 | 147 | 5 | 11d867bcb4f2471b4e13a5f7dc1c24286197f26d | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-04 | 177 | 147 | 5 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 3.03e-04 | 177 | 147 | 5 | 22b7cda748cf5e665be54ca5bae89f0c130d5e7f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.03e-04 | 177 | 147 | 5 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 178 | 147 | 5 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| Drug | torcetrapib | PDE4B EPPK1 ILF3 ANK3 ATRX IRGQ LINS1 RIF1 DST PRRC2C HSD3B2 DYNC1H1 | 2.06e-06 | 342 | 145 | 12 | ctd:C483909 |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A | 4.59e-06 | 195 | 145 | 9 | 1214_UP | |
| Drug | 3-doxylandrostanol | 2.07e-05 | 9 | 145 | 3 | CID000189075 | |
| Drug | cnicin | 2.73e-05 | 92 | 145 | 6 | CID000091176 | |
| Drug | Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.83e-05 | 188 | 145 | 8 | 1832_UP | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; PC3; HT_HG-U133A | 3.17e-05 | 191 | 145 | 8 | 1813_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.41e-05 | 193 | 145 | 8 | 3866_DN | |
| Drug | ICI 182,780; Down 200; 1uM; PC3; HT_HG-U133A | 3.54e-05 | 194 | 145 | 8 | 4429_DN | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.81e-05 | 196 | 145 | 8 | 5293_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.81e-05 | 196 | 145 | 8 | 5860_DN | |
| Drug | 26-nor-25-doxylcholestanol | 4.02e-05 | 11 | 145 | 3 | CID000125890 | |
| Drug | AC1NSPXR | 4.02e-05 | 11 | 145 | 3 | CID005313815 | |
| Drug | 20,25-diazacholesterol | 4.02e-05 | 11 | 145 | 3 | CID000009402 | |
| Drug | CHEMBL83995 | 4.03e-05 | 2 | 145 | 2 | CID009571169 | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; PC3; HT_HG-U133A | 4.09e-05 | 198 | 145 | 8 | 5869_DN | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; PC3; HT_HG-U133A | 4.09e-05 | 198 | 145 | 8 | 6314_DN | |
| Disease | choline measurement | 3.32e-06 | 130 | 142 | 7 | EFO_0010116 | |
| Disease | esterified cholesterol measurement | 3.74e-05 | 128 | 142 | 6 | EFO_0008589 | |
| Disease | phospholipid measurement | 6.18e-05 | 140 | 142 | 6 | EFO_0004639 | |
| Disease | chronic kidney disease (is_marker_for) | 1.17e-04 | 20 | 142 | 3 | DOID:784 (is_marker_for) | |
| Disease | pulse pressure measurement | USP34 ANK2 NEK10 WWP2 LAMA5 RREB1 LCP1 ITIH1 PHC2 PRDM9 ASAP2 CELF1 CELF2 EIF2AK4 DOT1L MBD5 NNT TNS3 | 1.30e-04 | 1392 | 142 | 18 | EFO_0005763 |
| Disease | phospholipids in medium HDL measurement | 1.45e-04 | 55 | 142 | 4 | EFO_0022295 | |
| Disease | lipoprotein measurement | 1.58e-04 | 105 | 142 | 5 | EFO_0004732 | |
| Disease | total lipids in medium HDL measurement | 1.78e-04 | 58 | 142 | 4 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 1.78e-04 | 58 | 142 | 4 | EFO_0022267 | |
| Disease | physical activity measurement | 1.92e-04 | 245 | 142 | 7 | EFO_0008002 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.06e-04 | 330 | 142 | 8 | EFO_0004529, EFO_0004612 | |
| Disease | phospholipids in HDL measurement | 2.17e-04 | 61 | 142 | 4 | EFO_0022293 | |
| Disease | low-density lipoprotein receptor-related protein 1, soluble measurement | 2.28e-04 | 5 | 142 | 2 | EFO_0801772 | |
| Disease | total lipids in HDL measurement | 2.46e-04 | 63 | 142 | 4 | EFO_0022307 | |
| Disease | serum IgE measurement | 2.61e-04 | 64 | 142 | 4 | EFO_0004579 | |
| Disease | ERO1-like protein alpha measurement | 3.41e-04 | 6 | 142 | 2 | EFO_0801582 | |
| Disease | hereditary spastic paraplegia 31 (implicated_via_orthology) | 3.41e-04 | 6 | 142 | 2 | DOID:0110782 (implicated_via_orthology) | |
| Disease | protocadherin beta-4 measurement | 3.41e-04 | 6 | 142 | 2 | EFO_0801976 | |
| Disease | interleukin 17 receptor B measurement | 3.41e-04 | 6 | 142 | 2 | EFO_0008176 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 measurement | 3.41e-04 | 6 | 142 | 2 | EFO_0801372 | |
| Disease | psychotic symptoms | 4.56e-04 | 74 | 142 | 4 | EFO_0005940 | |
| Disease | bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 measurement | 4.75e-04 | 7 | 142 | 2 | EFO_0802332 | |
| Disease | heparan-sulfate 6-o-sulfotransferase 1 measurement | 4.75e-04 | 7 | 142 | 2 | EFO_0020437 | |
| Disease | serum gamma-glutamyl transferase measurement | ATRX CYP7A1 BICRA PTBP1 RREB1 EMSY SLC39A8 SPPL2A SALL1 CELF1 CELF2 TLN1 PALM3 | 4.89e-04 | 914 | 142 | 13 | EFO_0004532 |
| Disease | free cholesterol in large HDL measurement | 5.84e-04 | 79 | 142 | 4 | EFO_0022157 | |
| Disease | Abdominal Cryptorchidism | 6.32e-04 | 8 | 142 | 2 | C1563730 | |
| Disease | Inguinal Cryptorchidism | 6.32e-04 | 8 | 142 | 2 | C1563731 | |
| Disease | zinc-alpha-2-glycoprotein measurement | 6.32e-04 | 8 | 142 | 2 | EFO_0802228 | |
| Disease | Bilateral Cryptorchidism | 6.32e-04 | 8 | 142 | 2 | C0431663 | |
| Disease | Unilateral Cryptorchidism | 6.32e-04 | 8 | 142 | 2 | C0431664 | |
| Disease | lipoprotein measurement, phospholipid measurement | 7.70e-04 | 85 | 142 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | complement C1q and tumor necrosis factor-related protein 9A measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0803293 | |
| Disease | dickkopf-like protein 1 measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0020324 | |
| Disease | cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0020296 | |
| Disease | cellular retinoic acid-binding protein 1 measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0801463 | |
| Disease | oxysterols receptor LXR-beta measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0801865 | |
| Disease | apolipoprotein D measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0020156 | |
| Disease | interleukin-34 measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0020505 | |
| Disease | leucine-rich repeat serine/threonine-protein kinase 2 measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0021876 | |
| Disease | urate measurement, bone density | TRPM6 TSHZ2 LAMA5 PAM16 LCP1 SALL1 EIF2AK4 DNAH9 ATP2B2 PRRC2B | 8.58e-04 | 619 | 142 | 10 | EFO_0003923, EFO_0004531 |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 8.61e-04 | 315 | 142 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | waist-hip ratio | ANK3 MYCBP2 TSHZ2 WWP2 RREB1 LCP1 TRIP12 REEP2 SLC39A8 PHC1 UBN1 CELF1 DOT1L DOCK6 CUX1 | 8.61e-04 | 1226 | 142 | 15 | EFO_0004343 |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 9.60e-04 | 321 | 142 | 7 | EFO_0004612, EFO_0004639 | |
| Disease | serine/threonine-protein kinase 16 measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0020724 | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | Cryptorchidism | 1.01e-03 | 10 | 142 | 2 | C0010417 | |
| Disease | interleukin-37 measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0020506 | |
| Disease | insulin growth factor-like family member 3 measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0801700 | |
| Disease | platelet component distribution width | CAPN12 LAMA5 PTBP1 LCP1 SLC30A1 SLC39A8 PRRC2C TLN1 ANKDD1B EIF2AK4 CUX1 | 1.10e-03 | 755 | 142 | 11 | EFO_0007984 |
| Disease | cerebrospinal fluid biomarker measurement | 1.21e-03 | 96 | 142 | 4 | EFO_0006794 | |
| Disease | tumor necrosis factor receptor superfamily member 11B measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0020801 | |
| Disease | schizophrenia, gastroesophageal reflux disease | 1.23e-03 | 11 | 142 | 2 | EFO_0003948, MONDO_0005090 | |
| Disease | motor function measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0010749 | |
| Disease | interleukin-10 receptor subunit alpha measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0021890 | |
| Disease | guanylate-binding protein 6 measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0801662 | |
| Disease | glycerol-3-phosphate dehydrogenase 1-like protein measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0801640 | |
| Disease | immunoglobulin isotype switching measurement | 1.25e-03 | 44 | 142 | 3 | EFO_0010128 | |
| Disease | chronic musculoskeletal pain | 1.47e-03 | 12 | 142 | 2 | EFO_0022195 | |
| Disease | complement component C7 measurement | 1.47e-03 | 12 | 142 | 2 | EFO_0008093 | |
| Disease | Seizures, Focal | 1.63e-03 | 104 | 142 | 4 | C0751495 | |
| Disease | kallikrein-12 measurement | 1.73e-03 | 13 | 142 | 2 | EFO_0008194 | |
| Disease | urinary albumin to creatinine ratio | 1.78e-03 | 179 | 142 | 5 | EFO_0007778 | |
| Disease | C-X-C motif chemokine 11 measurement | 2.01e-03 | 14 | 142 | 2 | EFO_0008057 | |
| Disease | C-reactive protein measurement | USP34 PDE4B ANK3 FAM210A PTBP1 RREB1 LCP1 TRIP12 LEPR SLC39A8 SALL1 CELF1 SPHKAP CUX1 | 2.09e-03 | 1206 | 142 | 14 | EFO_0004458 |
| Disease | hepatoblastoma (is_marker_for) | 2.32e-03 | 15 | 142 | 2 | DOID:687 (is_marker_for) | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 2.38e-03 | 55 | 142 | 3 | EFO_0022288 | |
| Disease | neuroblastoma | 2.43e-03 | 116 | 142 | 4 | EFO_0000621 | |
| Disease | Alzheimer disease | 2.48e-03 | 485 | 142 | 8 | MONDO_0004975 | |
| Disease | polyp of colon | 2.51e-03 | 56 | 142 | 3 | MONDO_0021400 | |
| Disease | neutrophil collagenase measurement | 2.64e-03 | 16 | 142 | 2 | EFO_0008248 | |
| Disease | cholesterol in medium HDL measurement | 2.91e-03 | 59 | 142 | 3 | EFO_0021903 | |
| Disease | SLAM family member 7 measurement | 2.98e-03 | 17 | 142 | 2 | EFO_0008287 | |
| Disease | Limb Deformities, Congenital | 2.98e-03 | 17 | 142 | 2 | C0206762 | |
| Disease | cholesterol to total lipids in IDL percentage | 3.06e-03 | 60 | 142 | 3 | EFO_0022233 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 3.06e-03 | 60 | 142 | 3 | EFO_0022282 | |
| Disease | free cholesterol in HDL measurement | 3.20e-03 | 61 | 142 | 3 | EFO_0022264 | |
| Disease | eosinophil percentage of leukocytes | 3.36e-03 | 746 | 142 | 10 | EFO_0007991 | |
| Disease | calcium measurement | 3.46e-03 | 628 | 142 | 9 | EFO_0004838 | |
| Disease | non-lobar intracerebral hemorrhage | 3.51e-03 | 63 | 142 | 3 | EFO_0010178 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 3.73e-03 | 19 | 142 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | total lipids in very large HDL measurement | 4.00e-03 | 66 | 142 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 4.00e-03 | 66 | 142 | 3 | EFO_0022298 | |
| Disease | smoking status measurement | CPNE8 PDE4B TSHZ2 BICRA WWP2 CHDH PHC2 SALL1 CELF2 UBAP2L CRACDL EIF3H PRRC2B | 4.05e-03 | 1160 | 142 | 13 | EFO_0006527 |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 4.10e-03 | 312 | 142 | 6 | EFO_0004612, EFO_0010351 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 4.30e-03 | 315 | 142 | 6 | EFO_0004574, EFO_0004612 | |
| Disease | diabetes mellitus | 4.35e-03 | 68 | 142 | 3 | EFO_0000400 | |
| Disease | cholesterol in very large HDL measurement | 4.53e-03 | 69 | 142 | 3 | EFO_0022229 | |
| Disease | periodontitis (biomarker_via_orthology) | 4.55e-03 | 21 | 142 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | neutrophil count, basophil count | 4.66e-03 | 224 | 142 | 5 | EFO_0004833, EFO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSILKNSQSGNALTA | 176 | Q96ND0 | |
| AAVNFQLNSHLSTLA | 6 | Q92564 | |
| FLSASINEALNNNGI | 196 | P26439 | |
| LAVNALSNSTTAGQA | 116 | P41181 | |
| LALLQQATSSSNLGA | 251 | O95319 | |
| NALQLQNLATLAAAA | 276 | O95319 | |
| QNLATLAAAAAAAQT | 281 | O95319 | |
| LSLASSNHLGKNLQL | 231 | O15372 | |
| NSLLFSHNAGQLVDT | 261 | Q86XM0 | |
| NLAVQNLKGSFSNAS | 1506 | Q9P2K8 | |
| LQNLAALAAAASAAQ | 261 | Q92879 | |
| QLSSANHSLQLASQI | 256 | P39880 | |
| EQANKLGAINSTLSN | 131 | Q86YB8 | |
| SNLSNSAGNAVLEAL | 26 | Q03828 | |
| IALVESNSINHNGAS | 721 | Q9UK96 | |
| LLSNSSFSQGHLQNI | 1406 | Q86UQ4 | |
| ASQKASELGHSLNEN | 236 | Q8N6T3 | |
| LLANSLSVHQLAAQG | 146 | Q9H9E1 | |
| LQANLGSVAGSSVLQ | 1481 | Q8TEK3 | |
| LAHKADVNAQSSTGN | 321 | O75179 | |
| SLSTVANEAHNNLGV | 1051 | Q9P1Y5 | |
| AHGSLAALVLQFQTN | 896 | A7MBM2 | |
| LNKNNSAIDSGINLT | 1206 | Q01814 | |
| QQQSLGARALASAGS | 21 | Q8NE62 | |
| GALQKNHALVTSANS | 116 | P24386 | |
| LSSKNGNRISSNNLE | 911 | Q6ZP01 | |
| LQSQLQLLQSASTGA | 91 | A6NDB9 | |
| KGNTALHIASLAGQA | 96 | Q01484 | |
| VALLLQHGASINASN | 826 | Q96NW4 | |
| ARNSAGQTLSAVQLH | 321 | O75147 | |
| LQSLQQALDGAKTHS | 1096 | Q7RTW8 | |
| ASALGHLSFLEQQQS | 1046 | Q92619 | |
| ALANAVLQAVNSGLL | 336 | Q8NG48 | |
| AAGLVSTQKLGSLNN | 301 | Q9H3P2 | |
| KGSLVQASEANLQAA | 341 | P19827 | |
| RTSAIKALNATGQAN | 301 | Q02083 | |
| KALNATGQANLSLEA | 306 | Q02083 | |
| LSAQLLSGGLINSNS | 1776 | Q03001 | |
| LQSNAVSLARDAANL | 731 | O43150 | |
| DSHLAINGSANRQSK | 446 | Q6DN90 | |
| LSANKQFLLTNNGHS | 81 | O43570 | |
| SLSALGNVIAALAGN | 296 | O14782 | |
| TISENLNLALNSASA | 191 | Q14651 | |
| QENLNLALNSASAIG | 191 | P13796 | |
| SLSSANAAGRIQQLH | 356 | Q6ZWH5 | |
| ANNGLVAQHSDTISL | 636 | Q96RD9 | |
| NNFTILTNLHGTSNK | 181 | Q07343 | |
| LAAALGQQFTQDASL | 196 | Q6PIU2 | |
| QNLGAVASSGSFQLL | 146 | A8MUP2 | |
| TASHLSQALQAALQD | 806 | Q92817 | |
| AINSIGASVANFNLT | 716 | P48357 | |
| LILSNNQLAALAAGA | 136 | Q9BTN0 | |
| HAQQLGQLALNLSSI | 2491 | O15230 | |
| QRGISLSHQNLAQSA | 906 | Q6NV74 | |
| LNQLGDLALSAAQSA | 851 | Q9H0A0 | |
| LHQVQLAGTSLQAAA | 51 | P14859 | |
| LAGTSLQAAAQSLNV | 56 | P14859 | |
| NSKFHLGSIINITAN | 286 | Q8TCU5 | |
| NSALVAQAGLSSGLQ | 846 | Q86XN7 | |
| ALHLASANGNSEVVQ | 176 | A0JP26 | |
| TANLLNASGSEQAQK | 136 | Q9NQV7 | |
| STKAGSLGINLVAAN | 2116 | P46100 | |
| AAGFHLNNQLTQTLT | 651 | Q6ZSI9 | |
| SALNSLNLSFAGLEQ | 276 | P08571 | |
| AQAENHLNGKNSSLT | 31 | Q96FT9 | |
| SAQSALFLQHGLATQ | 1426 | Q96HP0 | |
| LENALKAASGTQNNV | 356 | P10643 | |
| QSAQHALRLAAFGQL | 316 | Q12906 | |
| KGNTALHIASLAGQA | 106 | Q12955 | |
| NKSNVLLQGASTQAS | 296 | O43303 | |
| IAQHQNLLLANTTSA | 326 | P35475 | |
| ASSLLSAAAKAQLAN | 576 | Q9P267 | |
| IKQLQNISLAAASGG | 4486 | Q14204 | |
| NNNKLSLSNAISTAL | 4571 | Q14204 | |
| NDTFIKTLQGHALNS | 126 | P22680 | |
| ANAVANAAIQHNASL | 116 | Q7Z589 | |
| ALTAAQAALNTLNKT | 3156 | Q9NYC9 | |
| SLKSNVRGIHANVAA | 2566 | Q9NYQ7 | |
| KNLSAAVATTLNGNS | 291 | Q9NZM4 | |
| LNASTLALALANLNG | 91 | O75462 | |
| LTAQLTAAAAAANTL | 236 | Q9UPN6 | |
| ALQNQSDSLLALAGA | 131 | Q6ZMJ2 | |
| QQLAAAAGLAQSLAS | 291 | Q9NSC2 | |
| QQVSAAVALLSQKAG | 266 | Q9UJQ4 | |
| AVALLSQKAGSQGLS | 271 | Q9UJQ4 | |
| NLLANTIDNFTHGLA | 221 | Q96H72 | |
| AIKIQRSNGLIHSAN | 16 | Q99661 | |
| NSTAGIGDLNQLSAA | 6 | Q86YQ8 | |
| LQLQLNSLGAAAAAA | 341 | Q9UJU5 | |
| QARDQTAALLNSAGL | 126 | Q8WZA9 | |
| VNLALALAANDSSKA | 86 | Q8TB37 | |
| TLIHSANQINGSFAL | 416 | Q96DY7 | |
| NQKDLLVSSGSNNSL | 1011 | Q5THK1 | |
| AAAHSNLASVLQQQG | 361 | O15294 | |
| QELGHSQSALASAQR | 1176 | Q14980 | |
| SAAVQAATKSQGALA | 131 | Q9H6H4 | |
| ALHLASANGNSEVVQ | 176 | B2RU33 | |
| NKNQSSRHLSIGSLN | 56 | Q6NXP6 | |
| SQGLAALAAFISSVN | 556 | Q13423 | |
| ALHLASANGNSEVVQ | 176 | Q86YR6 | |
| LLEAANTSGNASLQL | 31 | Q9NSD7 | |
| NSHNTSLVINNLVDG | 776 | Q2M3C7 | |
| NLQHLSGNATLTLIA | 266 | P19320 | |
| SQNSELSSAALQALG | 66 | Q5UIP0 | |
| ENAALLTANGLHLSQ | 276 | Q8N3V7 | |
| AGNILQHSKAQELSA | 91 | Q9BXW7 | |
| HQQNFTGLSTLSKNI | 1551 | Q96Q15 | |
| TAFLQNAGQAHLISQ | 2601 | Q96Q15 | |
| SFLHLNNAVSINLGN | 96 | O94933 | |
| GATLTSLLAQAQAQA | 2486 | P58107 | |
| GATLTSLLAQAQAQA | 4621 | P58107 | |
| LAKAQSGLAFQQTSN | 2501 | Q9Y520 | |
| RAQNSLGSQHVSLNL | 321 | Q9Y286 | |
| QNAQGSQHISLSLSL | 331 | Q9NYZ4 | |
| LQAISAILTNNGSHA | 296 | O75592 | |
| ANASTLNDGAAALVL | 281 | P24752 | |
| SANNLDLLLNSGTLA | 526 | Q9BVR0 | |
| TAANSAAELLKQGAA | 1296 | Q68CZ2 | |
| SLQIATRNGHASLVN | 271 | A6NHY2 | |
| AATAQLQNLLGTHNL | 516 | Q8N957 | |
| QHLSSAQLQSLAAVQ | 96 | Q8IXK0 | |
| LGTASVNLSNVLKNN | 96 | O00308 | |
| LKGTNLSASEQLNLA | 401 | Q9BX84 | |
| FKTAQALAQLAAQHS | 366 | Q14157 | |
| LNLAANAAVTAAAKG | 126 | Q9BRK0 | |
| HTQAVNLLKNASGSI | 1926 | O75970 | |
| NSGSQLASLLKVHLQ | 571 | Q6SZW1 | |
| AASNAHLLQSKSGTQ | 556 | Q92766 | |
| SAQLALIAASQSFLQ | 981 | Q9Y490 | |
| IISLNAAQLAAAAQA | 421 | Q02086 | |
| QLTAAQEAILHASGN | 21 | Q8TCT8 | |
| LAASLALALNGVFTN | 91 | Q8NEB5 | |
| DLFSQALQHALQASG | 316 | Q96S82 | |
| VQTHSLQALQGFTAA | 326 | Q5GH76 | |
| LQALQGFTAAASLVS | 331 | Q5GH76 | |
| VKLQDALASNAGLTQ | 1811 | Q5JSZ5 | |
| GTAQAQALGLAQLAA | 536 | P78364 | |
| TNVALNTFGALASLN | 701 | Q68DE3 | |
| KTGSLEAAQALQNLA | 411 | Q14997 | |
| SALQSVLNNHLGKAT | 696 | Q9NRE2 | |
| VNALDNLGQTSLHRA | 426 | Q9H2K2 | |
| AAASNLSGLSLQEAQ | 46 | Q9Y3D7 | |
| AAQLLAASLHLAKAQ | 891 | Q8IYT8 | |
| LNFLAEQALALGQSS | 736 | Q9NPG3 | |
| LAQASALHLNAQQVS | 361 | Q8TEQ8 | |
| VFGANLSLSAAQLQH | 36 | Q9C0K1 | |
| SLQAAISENTKSGNH | 296 | P0C1S8 | |
| LAGLSQITNQLHTFN | 331 | Q70CQ2 | |
| TLVANTSNSNGLKLD | 191 | Q9Y6M5 | |
| SSKAQQLLQGLQASD | 436 | Q14669 | |
| SAALQNANTKCNGLL | 4906 | Q5T4S7 | |
| TGLLALSGALAAQAQ | 151 | Q04725 | |
| LSGALAAQAQLAAAV | 156 | Q04725 | |
| LAGAGNSVLLVSNLN | 331 | P26599 | |
| SLRHQQVALLATANG | 516 | P36508 | |
| ALAGATSLAQLNLNL | 51 | Q5JTD7 | |
| IALQGNSKLTHLNFS | 776 | Q86W25 |